• Distributable income (“DI”) increased 14.6% year-on-year to S$57.2 million • Distribution Per Unit (“DPU”) rose 14.6% year-on-year to 8.77 Singapore cents mainly due to the step-up lease arrangements across the Singapore and France portfolios •…
• Distributable income (“DI”) increased 14.6% year-on-year to S$57.2 million
• Distribution Per Unit (“DPU”) rose 14.6% year-on-year to 8.77 Singapore cents
mainly due to the step-up lease arrangements across the Singapore and
France portfolios
• Rent uplift from revenue-sharing arrangements with two Singapore hospitals,
outperforming minimum guaranteed rent
• Completed strategic divestment of a Japan nursing home at a premium as part
of ongoing portfolio rejuvenation strategy
• Maintained a healthy balance sheet with gearing of 33.8% and no long-term
refinancing requirements until March 2027
Total Portfolio 1H 2026
S$’000
1H 2025
S$’000
Variance
%
Gross Revenue 77,079 78,308 (1.6)
Net Property Income 72,361 73,844 (2.0)
DI to Unitholders (net amount
retained for capital expenditure)
57,240 49,923 14.6
Distribution Per Unit (cents)
1
- DPU for the period
- Annualised DPU
8.77
17.54
7.65
15.30
14.6
14.6
Annualised Distribution Yield
(%) based on closing market price
of S$4.05 as at 30 June 2026
4.33 3.78 14.6
1
In computing the distribution per unit, the number of units in issue as at the end of each period is used.
2
Singapore, 04 August 2026 – Parkway Trust Management Limited (the “Manager”),
as manager of Parkway Life Real Estate Investment Trust (“PLife REIT” or the
“Group”), one of Asia’s largest listed healthcare REITs with a portfolio of S$2.56
2
billion, today announced its results for the half year ended 30 June 2026 (“1H 2026”).
Despite foreign exchange headwinds from Japan and lower rental income arising from
the tenant exit affecting five Japan nursing home properties, PLife REIT delivered
higher DI and DPU, supported by resilient organic growth from its Singapore and
France portfolios.
PLife REIT's Singapore hospital portfolio continued to underpin the REIT's organic
growth during the period. Under the Annual Rent Review Formula
3
applicable from
FY2026 onwards, the minimum rent will increase to S$99.1 million based on a
Consumer Price Index ("CPI") of 0.9%. As the impact of the step-up lease arrangement
over the last 3 years and 1% guaranteed annual growth of the Singapore portfolio has
been straight-lined across the lease term and consistently applied since August 2022
in accordance with the accounting treatment, there is no significant revenue movement
year-on-year saved for the CPI-linked rental adjustment of 0.9%. In addition, the
portfolio recorded a S$0.8 million uplift for the first quarter of 2026 (“Q1 2026”) under
the revenue-sharing arrangement following stronger operating performance at
Gleneagles Hospital and Parkway East Hospital. Any revenue-sharing contribution for
Q2 2026, if applicable, will be recognised in the next quarter.
Overall, gross revenue for the half year stood at S$77.1 million, while net property
income was S$72.4 million. Compared to the corresponding period last year, gross
revenue and net property income have declined by 1.6% and 2.0% respectively,
mainly due to the depreciation of the Japanese Yen and lower rental income from
affected Japan assets. These were partially offset by continued contributions from the
Singapore portfolio. As the REIT has hedged its net income from Japan, the lower
2
Based on latest appraised values (excludes right-of-use assets) as at 31 December 2025
3
The Annual Rent Review Formula which applies to rental contributions for FY2026 is based on the higher of (i) {1+(CPI+1%) X
Initial Rent of $97.2 million} or (ii) {Base Rent + Variable Rent}
3
reported revenue will be substantially mitigated by foreign exchange gains realised
upon settlement of its forward contracts.
Amount available for distribution, which is computed on actual rent receipts, increased
16.2% year-on-year. The growth was primarily driven by the higher rental contributions
from the Singapore hospitals’ Annual Rent Review formula and step-up lease
arrangement from the France portfolio, as well as the absence of the France tax
provision recognised in the corresponding period last year
4
. Notwithstanding the
above, any additional DI arising from the outperformance of the Singapore hospitals
is only finalised when the full year revenue is determined. Accordingly, the S$0.8
million uplift recognised for Q1 2026 has not been included in the current distribution
and will be distributed together with any full-year revenue-sharing entitlement, if
applicable, in 2H 2026. Consequently, DI and DPU increased 14.6% year-on-year to
S$57.2 million and 8.77 Singapore cents respectively.
Resilient Overseas Portfolio Enhanced Through Active Portfolio Management
In Japan, the Group continued to proactively optimise its portfolio while managing
near-term operational headwinds. On 30 June 2026, PLife REIT completed the
divestment of a nursing home for approximately JPY1.17 billion (approximately S$9.4
million) as part of its ongoing portfolio rejuvenation strategy. The transaction was
completed at a 38% premium to its acquisition price and 5% above its latest
independent valuation, generating a gain on disposal of approximately S$0.6 million
while strengthening the long-term quality and growth potential of the Japan portfolio.
The France properties continued to provide stable earnings contributions during the
period. Step-up lease arrangements across the France portfolio supported the
increase in DI. Compared with the corresponding period last year, DI also benefited
from the absence of the tax provision following the tax exemption approvals obtained
from the Inland Revenue Authority of Singapore (IRAS) and Ministry of Finance (MOF)
4
A $0.9 million tax provision was made in 1H 2025 prior to the approval obtained from IRAS & MoF for the France portfolio's tax
exemption on foreign-sourced dividend and interest income in 2H 2025
4
in the second half of 2025 on foreign-sourced dividend and interest income from the
France portfolio.
Foreign exchange risks continue to be actively managed through natural hedging,
cross-currency swaps and forward contracts on the income derived from the Japan
and France portfolios,
Mr. Yong Yean Chau, Chief Executive Officer of the Manager, said: "Our first half
results demonstrate the resilience of PLife REIT's healthcare portfolio. The Singapore
hospitals continue to deliver sustainable organic growth under the Annual Rent Review
Formula, while the successful divestment of a mature Japan asset reflects our
disciplined approach to portfolio optimisation. Together, these initiatives have enabled
us to deliver another meaningful increase in DI and DPU despite external headwinds."
Strong Balance Sheet Provides Financial Flexibility
PLife REIT continues to maintain a prudent capital structure. As at 30 June 2026,
gearing stood at 33.8%, while the all-in debt cost remained low at 1.67% and interest
coverage ratio was 8.2 times. The Group has no long-term refinancing requirements
until March 2027, providing flexibility amid the evolving interest rate environment with
approximately 96% of the Group's interest rate exposure hedged, providing greater
stability and visibility over distributable income.
Mr. Yong added: “Looking ahead, we will continue to focus on prudent portfolio
management and asset enhancement initiatives to strengthen portfolio quality and
long-term resilience. At the same time, we remain disciplined in evaluating
opportunities that create sustainable value for our unitholders."
END
5
About Parkway Life REIT
Parkway Life Real Estate Investment Trust (“PLife REIT”) is one of Asia’s largest listed
healthcare REITs by asset size. It invests in income-producing real estate and real
estate related assets that are used primarily for healthcare and healthcare-related
purposes (including but are not limited to, hospitals, healthcare facilities and real
estate and/or real estate assets used in connection with healthcare research,
education, and the manufacture or storage of drugs, medicine and other healthcare
goods and devices). PLife REIT owns a well-diversified portfolio of 73 properties, with
a total portfolio size of approximately S$2.56 billion. It owns the largest portfolio of
strategically located private hospitals in Singapore comprising Mount Elizabeth
Hospital, Gleneagles Hospital and Parkway East Hospital. In addition, it has 59 assets
of high-quality nursing home and care facility properties in various prefectures of
Japan, and 11 assets of high-quality nursing homes well located across six regions in
France.
For media queries, please contact:
H/Advisors
Sherilyn Yang – [email protected] / (65) 9844 0714
Gabriel Chia – [email protected] / (65) 9738 8575
6
Important Notice
This press release is for information only and does not constitute an invitation or offer
to acquire, purchase or subscribe for units in Parkway Life Real Estate Investment
Trust (“PLife REIT” and the units in PLife REIT, the “Units”).
The value of the Units and the income derived from them may fall as well as rise. The
Units are not obligations of, deposits in, or guaranteed by, Parkway Trust Management
Limited, as Manager of PLife REIT, or any of its affiliates. Investors have no right to
request the Manager to redeem their Units while the Units are listed. It is intended that
Unitholders of PLife REIT may only deal in their Units through trading on Singapore
Exchange Securities Trading Limited (the “SGX-ST”). Listing of the Units on the
SGXST does not guarantee a liquid market for the Units. The past performance of
PLife REIT or the Manager is not necessarily indicative of the future performance of
PLife REIT or the Manager. An investment in Units is subject to investment risks,
including the possible loss of the principal amount invested.